| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 996.60M | 1.10B | 1.11B | 1.11B | 950.50M |
| Gross Profit | 198.30M | 813.20M | 120.80M | 244.70M | 207.10M |
| EBITDA | 210.10M | 150.00M | 138.60M | 188.10M | 156.30M |
| Net Income | 21.10M | 50.30M | 47.30M | 88.00M | 73.80M |
Balance Sheet | |||||
| Total Assets | 984.80M | 1.08B | 1.02B | 1.03B | 925.40M |
| Cash, Cash Equivalents and Short-Term Investments | 126.50M | 118.60M | 124.50M | 117.70M | 127.30M |
| Total Debt | 360.70M | 393.70M | 356.80M | 318.10M | 223.80M |
| Total Liabilities | 635.90M | 687.80M | 626.10M | 602.30M | 575.80M |
| Stockholders Equity | 316.60M | 353.70M | 360.30M | 389.00M | 310.60M |
Cash Flow | |||||
| Free Cash Flow | 53.50M | 17.20M | 18.10M | -37.40M | 74.60M |
| Operating Cash Flow | 120.60M | 113.30M | 78.50M | 20.60M | 106.20M |
| Investing Cash Flow | -55.00M | -86.00M | -60.20M | -57.00M | -13.90M |
| Financing Cash Flow | -99.50M | -33.00M | -2.00M | 23.40M | -112.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £7.76B | 33.19 | 13.71% | 1.93% | -31.27% | -13.26% | |
71 Outperform | £1.22B | 31.10 | 33.12% | 1.01% | 24.42% | 103.25% | |
71 Outperform | £7.23B | 29.75 | 24.91% | 1.29% | 4.25% | 29.89% | |
67 Neutral | £2.56B | 22.64 | 20.10% | 2.04% | 3.03% | 13.76% | |
62 Neutral | £1.21B | 22.50 | 8.58% | 3.30% | -3.96% | 192.10% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | £623.32M | 29.96 | 6.66% | 608.88% | ― | ― |